154 related articles for article (PubMed ID: 3571754)
1. Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
Greenberg ML; Lerman BB; Shipe JR; Kaiser DL; DiMarco JP
J Am Coll Cardiol; 1987 May; 9(5):1148-55. PubMed ID: 3571754
[TBL] [Abstract][Full Text] [Related]
2. Concentration response relationships of amiodarone and desethylamiodarone.
Connolly SJ; Gupta RN; Hoffert D; Roberts RS
Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
Somani P; Simon VA; McManus K
Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
[TBL] [Abstract][Full Text] [Related]
4. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of electrophysiologic and pharmacologic stability during an abbreviated oral loading regimen of amiodarone.
Rosenfeld LF; Kennedy EE; Perlmutter RA; Bookbinder MJ; McPherson CA; Batsford WP
Am Heart J; 1987 Dec; 114(6):1367-74. PubMed ID: 3687689
[TBL] [Abstract][Full Text] [Related]
6. Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.
Rotmensch HH; Belhassen B; Swanson BN; Shoshani D; Spielman SR; Greenspon AJ; Greenspan AM; Vlasses PH; Horowitz LN
Ann Intern Med; 1984 Oct; 101(4):462-9. PubMed ID: 6476633
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
8. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Saksena S; Rothbart ST; Cappello G
Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
[TBL] [Abstract][Full Text] [Related]
9. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
[TBL] [Abstract][Full Text] [Related]
10. [Control of anti-arrhythmia therapy with amiodarone. Value of the determination of blood levels].
Nitsch J; Lüderitz B
Dtsch Med Wochenschr; 1984 Mar; 109(13):492-5. PubMed ID: 6423357
[TBL] [Abstract][Full Text] [Related]
11. High dose oral amiodarone loading: electrophysiologic effects and clinical tolerance.
Evans SJ; Myers M; Zaher C; Simonson J; Nalos P; Vaughn C; Oseran D; Gang E; Peter T; Mandel W
J Am Coll Cardiol; 1992 Jan; 19(1):169-73. PubMed ID: 1729329
[TBL] [Abstract][Full Text] [Related]
12. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE
Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129
[TBL] [Abstract][Full Text] [Related]
13. Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite.
Talajic M; DeRoode MR; Nattel S
Circulation; 1987 Jan; 75(1):265-71. PubMed ID: 3791608
[TBL] [Abstract][Full Text] [Related]
14. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Nattel S; Davies M; Quantz M
Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801
[TBL] [Abstract][Full Text] [Related]
15. Clinical electrophysiologic effects of a single high oral dose of amiodarone.
Deharo JC; Durand A; Macaluso G; Malaterre H; Le Tallec L; Panagides D; Bory M; Djiane P
Fundam Clin Pharmacol; 1997; 11(3):275-80. PubMed ID: 9243260
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
Baerman JM; Annesley T; DiCarlo LA; Foley MK; Nicklas JM; Crevey BJ; Morady F
Am Heart J; 1986 Apr; 111(4):644-8. PubMed ID: 3953386
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the QT interval and plasma amiodarone concentration in patients on long-term therapy.
Burgess CD; Siebers RW; Purdie GL; Taylor C; Maling TJ
Eur J Clin Pharmacol; 1987; 33(2):115-8. PubMed ID: 3691605
[TBL] [Abstract][Full Text] [Related]
18. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
19. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Hamer AW; Finerman WB; Peter T; Mandel WJ
Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
[TBL] [Abstract][Full Text] [Related]
20. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
